Search research articles
Contact Us
Filters
Showing results (11-20 of 109) with videos related to
Page
of 11
Sort By:
Rivista Di Psichiatria
|
April 29, 2014
"Legal highs": safe and legal "heavens"? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK
Ornella Corazza, Pierluigi Simonato, John Corkery, et al.
Human Psychopharmacology
|
July 29, 2015
Injecting eye-drops: a mini-review on the non-clinical use of tropicamide
Francesco Saverio Bersani, Claudio Imperatori, Mariya Prilutskaya, et al.
Rivista Di Psichiatria
|
June 24, 2010
[New drugs of abuse on the Web: the role of the Psychonaut Web Mapping Project]
Fabrizio Schifano, Alessandra Ricciardi, Ornella Corazza, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
|
November 8, 2024
Captagon: A comprehensive bibliometric analysis (1962-2024) of its global impact, health and mortality risks
Seraphina Fong, Alessandro Carollo, Andrea Rossato, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
June 13, 2012
2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review
John M Corkery, Simon Elliott, Fabrizio Schifano, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
|
June 3, 2026
Captagon: A comprehensive bibliometric analysis (1962-2024) of its global impact, health and mortality risks
Seraphina Fong, Alessandro Carollo, Andrea Rossato, et al.
Drug Testing and Analysis
|
March 16, 2024
Performance-enhancing substances in sport: A scientometric review of 75 years of research
Alessandro Carollo, Ornella Corazza, Maria Mantovani, et al.
CNS & Neurological Disorders Drug Targets
|
April 18, 2017
Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset
Giovanni Martinotti, Rita Santacroce, Duccio Papanti, et al.
Human Psychopharmacology
|
July 25, 2013
MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update
John M Corkery, Simon Elliott, Fabrizio Schifano, et al.
Human Psychopharmacology
|
May 26, 2017
Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 109) with videos related to
Sort By:
Page
of 11
Rivista Di Psichiatria
|
April 29, 2014
"Legal highs": safe and legal "heavens"? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK
Ornella Corazza, Pierluigi Simonato, John Corkery, et al.
Human Psychopharmacology
|
July 29, 2015
Injecting eye-drops: a mini-review on the non-clinical use of tropicamide
Francesco Saverio Bersani, Claudio Imperatori, Mariya Prilutskaya, et al.
Rivista Di Psichiatria
|
June 24, 2010
[New drugs of abuse on the Web: the role of the Psychonaut Web Mapping Project]
Fabrizio Schifano, Alessandra Ricciardi, Ornella Corazza, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
|
November 8, 2024
Captagon: A comprehensive bibliometric analysis (1962-2024) of its global impact, health and mortality risks
Seraphina Fong, Alessandro Carollo, Andrea Rossato, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
June 13, 2012
2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review
John M Corkery, Simon Elliott, Fabrizio Schifano, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
|
June 3, 2026
Captagon: A comprehensive bibliometric analysis (1962-2024) of its global impact, health and mortality risks
Seraphina Fong, Alessandro Carollo, Andrea Rossato, et al.
Drug Testing and Analysis
|
March 16, 2024
Performance-enhancing substances in sport: A scientometric review of 75 years of research
Alessandro Carollo, Ornella Corazza, Maria Mantovani, et al.
CNS & Neurological Disorders Drug Targets
|
April 18, 2017
Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset
Giovanni Martinotti, Rita Santacroce, Duccio Papanti, et al.
Human Psychopharmacology
|
July 25, 2013
MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update
John M Corkery, Simon Elliott, Fabrizio Schifano, et al.
Human Psychopharmacology
|
May 26, 2017
Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, et al.
Page
of 11